Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1973 1
1974 1
1991 1
1992 1
1994 1
1999 1
2001 2
2003 3
2004 2
2005 2
2006 3
2007 3
2010 1
2011 3
2012 5
2013 2
2014 3
2015 5
2016 4
2017 7
2018 3
2019 4
2020 13
2021 10
2022 7
2023 8
2024 6
2025 11
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Pertpy: an end-to-end framework for perturbation analysis.
Heumos L, Ji Y, May L, Green TD, Peidli S, Zhang X, Wu X, Ostner J, Schumacher A, Hrovatin K, Müller M, Chong F, Sturm G, Tejada A, Dann E, Dong M, Pinto G, Bahrami M, Gold I, Rybakov S, Namsaraeva A, Moinfar AA, Zheng Z, Roellin E, Mekki I, Sander C, Lotfollahi M, Schiller HB, Theis FJ. Heumos L, et al. Among authors: green td. Nat Methods. 2026 Feb;23(2):350-359. doi: 10.1038/s41592-025-02909-7. Epub 2025 Dec 31. Nat Methods. 2026. PMID: 41476114 Free PMC article.
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.
Fisher-Wellman KH, Lutze RD, Kirkland LG, Beak JY, Morrissey SM, Sandroni PB, Huang W, Bailon JD, Schroder MA, Albrecht LA, Goyal M, Chin AL, Green TD, McClung JM, Montgomery MM, Hagen JT, Chrest BR, Zawistowski JS, Stuhlmiller TJ, Gomez SM, Prathumsap N, Zhang Q, Zhang J, Xu W, Zhang L, Meier JA, Carey LA, Schisler JC, Johnson GL, Jensen BC. Fisher-Wellman KH, et al. Among authors: green td. bioRxiv [Preprint]. 2025 Sep 8:2025.09.05.671511. doi: 10.1101/2025.09.05.671511. bioRxiv. 2025. PMID: 40964318 Free PMC article. Preprint.
Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities.
Scurlock AM, Fleischer DM, Toit GD, Arends NJT, Pongracic JA, Trujillo J, Turner P, Vogelberg C, Bee KJ, Green TD, Meney J, Bois T, Campbell DE, Sampson HA, Burks AW. Scurlock AM, et al. Among authors: green td. Ann Allergy Asthma Immunol. 2025 Aug;135(2):203-210. doi: 10.1016/j.anai.2025.04.002. Epub 2025 Apr 7. Ann Allergy Asthma Immunol. 2025. PMID: 40204253 Free article. Clinical Trial.
Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy.
Hagen JT, Montgomery MM, Aruleba RT, Chrest BR, Krassovskaia P, Green TD, Pacheco EA, Kassai M, Zeczycki TN, Schmidt CA, Bhowmick D, Tan SF, Feith DJ, Chalfant CE, Loughran TP Jr, Liles D, Minden MD, Schimmer AD, Shakil MS, McBride MJ, Cabot MC, McClung JM, Fisher-Wellman KH. Hagen JT, et al. Among authors: green td. Sci Adv. 2025 Apr 11;11(15):eadu5511. doi: 10.1126/sciadv.adu5511. Epub 2025 Apr 9. Sci Adv. 2025. PMID: 40203117 Free PMC article.
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Anvari S, Berger WE, Bird JA, Chan ES, Chinthrajah RS, Chong HJ, Fineman SM, Fleischer DM, Gonzalez-Reyes E, Kim EH, Lanser BJ, MacGinnitie A, Mehta H, Petroni D, Rupp N, Schneider LC, Scurlock AM, Sher LD, Shreffler WG, Sindher SB, Wood R, Yang WH, Sampson HA, Bois T, Green TD, Campbell DE, Bee KJ, Bégin P. Pongracic JA, et al. Among authors: green td. J Allergy Clin Immunol Pract. 2025 May;13(5):1190-1200.e3. doi: 10.1016/j.jaip.2025.02.024. Epub 2025 Feb 27. J Allergy Clin Immunol Pract. 2025. PMID: 40023371 Free article. Clinical Trial.
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Greenhawt M, Albright D, Anvari S, Arends N, Arkwright PD, Bégin P, Blümchen K, Brown-Whitehorn T, Cassell H, Chan ES, Ciaccio CE, Deschildre A, Divaret-Chauveau A, Dorris S, Dorsey M, Du Toit G, Eiwegger T, Erlewyn-Lajeunesse M, Fleischer DM, Ford LS, Garcia-Lloret M, O'B Hourihane J, Jay N, Jones SM, Kim EH, Kloepfer K, Leonard S, Lezmi G, Lieberman J, Lomas J, Makhija M, O'Sullivan M, Parrish C, Peake J, Perrett KP, Petroni D, Pongracic JA, Quinn P, Robison RG, Sanders G, Schneider L, Sharma H, Sindher SB, Trujillo J, Turner PJ, Tuttle K, Upton J, Varshney P, Vickery BP, Vogelberg C, Wainstein B, Wang J, Wood R, Bee KJ, Campbell DE, Green TD, Rouissi R, Bahnson HT, Bois T, Sampson HA, Burks AW. Greenhawt M, et al. Among authors: green td. J Allergy Clin Immunol Pract. 2025 May;13(5):1176-1187.e7. doi: 10.1016/j.jaip.2025.02.004. Epub 2025 Feb 14. J Allergy Clin Immunol Pract. 2025. PMID: 39956162 Free article. Clinical Trial.
102 results